Latest AI and machine learning research in skin cancer for healthcare professionals.
MySkinSelfie is a mobile phone application for skin self-monitoring, enabling secure sharing of pati...
Researching the specificity of TCR contributes to the development of immunotherapy and provides ne...
We investigate the potential of self-supervision in improving the accuracy of deep learning models...
Gene expression profiling of new or modified cell lines becomes routine today; however, obtaining co...
The progression of lung adenocarcinoma (LUAD) from atypical adenomatous hyperplasia (AAH) to invasiv...
Lung adenocarcinoma (LUAD) is a leading cause of cancer-related deaths, and improving prognostic acc...
Melanoma, a highly malignant tumour, presents significant challenges due to its cellular heterogenei...
BACKGROUND: Use of artificial intelligence (AI), or machine learning, to assess dermoscopic images o...
The adaptive immune response plays a vital role in eliminating infected and aberrant cells from the ...
With the advent of novel cancer treatment options such as immunotherapy, studying the tumour immun...
BACKGROUND: Melanoma is one of the most malignant forms of skin cancer, with a high mortality rate i...
This manuscript presents a comprehensive investigation into the role of lactate metabolism-related g...
In patients with nasopharyngeal carcinoma (NPC), the alteration of immune responses in peripheral bl...
PURPOSE: To use modern machine learning approaches to enhance and automate the feature extraction fr...
While significant strides have been made in predicting neoepitopes that trigger autologous CD4+ T ce...
Recent advances in microfluidics and sequencing technologies allow researchers to explore cellular h...
Tumor molecular data sets are becoming increasingly complex, making it nearly impossible for humans ...
Precise and personalized drug application is crucial in the clinical treatment of complex diseases. ...
BACKGROUND: Timely diagnosis plays a critical role in determining melanoma prognosis, prompting the ...
UNLABELLED: Programmed death-ligand 1 (PD-L1) IHC is the most commonly used biomarker for immunother...